Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O3SA
|
||||
Former ID |
DIB009128
|
||||
Drug Name |
ATL-801
|
||||
Synonyms |
BWA-1433; Adenosine A2b receptor antagonists (coronary artery occlusion), Pennsylvania State University;Adenosine A2b receptor antagonists (diabetes), Pennsylvania State University
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [467715] | ||
Company |
Pennsylvania State University
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H22N4O4
|
||||
InChI |
InChI=1S/C20H22N4O4/c1-3-11-23-18-16(19(27)24(12-4-2)20(23)28)21-17(22-18)14-8-5-13(6-9-14)7-10-15(25)26/h5-10H,3-4,11-12H2,1-2H3,(H,21,22)(H,25,26)/b10-7+
|
||||
InChIKey |
UGCOFEOEBHUEHA-JXMROGBWSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2b receptor | Target Info | Antagonist | [543534] | |
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
TCR Signaling Pathway | |||||
Pathway Interaction Database | C-MYB transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.